The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Abstract
Gene-based therapies for cancer in clinical trials include strategies that involve augmentation of immunotherapeutic and chemotherapeutic approaches. These strategies include ex vivo and in vivo cytokine gene transfer, drug sensitization with genes for prodrug delivery, and the use of drug-resistance genes for bone marrow protection from high-dose chemotherapy. Inactivation of oncogene expression and gene replacement for tumor suppressor genes are among the strategies for targeting the underlying genetic lesions in the cancer cell. A review of clinical trial results to date, primarily in patients with very advanced cancers refractory to conventional treatments, indicates that these treatments can mediate tumor regression with acceptably low toxicity. Vector development remains a critical area for future research. Important areas for future research include modifying viral vectors to reduce toxicity and immunogenicity, increasing the transduction efficiency of nonviral vectors, enhancing vector targeting and specificity, regulating gene expression, and identifying synergies between gene-based agents and other cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Research works printed but not linked: 147
- Blaese, 1995, Science, 270, 475, 10.1126/science.270.5235.475 · DOI · Paper page
- Kiem, 1995, Current opinion in oncology, 7, 107, 10.1097/00001622-199503000-00003 · doi:10.1097/00001622-199503000-00003
- Miller, 1995, The FASEB Journal, 9, 190, 10.1096/fasebj.9.2.7781922 · DOI · Paper page
- Crystal, 1995, Science, 270, 404, 10.1126/science.270.5235.404 · DOI · Paper page
- Herrmann, 1995, Journal of molecular medicine (Berlin, Germany), 73, 157
- Descamps, 1996, Journal of molecular medicine (Berlin, Germany), 74, 183, 10.1007/s001090050021 · doi:10.1007/s001090050021
- 1995, Cancer gene therapy, 4, 291
- Torres, 1995, Human gene therapy, 6, 133, 10.1089/hum.1995.6.2-133 · doi:10.1089/hum.1995.6.2-133
- Fearon, 1990, Cell, 60, 397, 10.1016/0092-8674(90)90591-2 · DOI · Paper page
- Asher, 1991, The Journal of Immunology, 146, 3227, 10.4049/jimmunol.146.9.3227 · DOI · Paper page
- Golumbek, 1991, Science, 254, 713, 10.1126/science.1948050 · DOI · Paper page
- Gansbacher, 1990, Cancer Research, 50, 7820
- Gansbacher, 1990, Journal of Experimental Medicine, 172, 1217, 10.1084/jem.172.4.1217 · DOI · Paper page
- Karp, 1993, The Journal of Immunology, 150, 896, 10.4049/jimmunol.150.3.896 · DOI
- Porgador, 1993, International journal of cancer. Journal international du cancer, 53, 471, 10.1002/ijc.2910530320 · doi:10.1002/ijc.2910530320
- Tsai, 1993, JNCI Journal of the National Cancer Institute, 85, 546, 10.1093/jnci/85.7.546 · doi:10.1093/jnci/85.7.546
- Restifo, 1992, Journal of Experimental Medicine, 175, 1423, 10.1084/jem.175.6.1423 · DOI · Paper page
- Gastl, 1992, Cancer Research, 52, 6229
- Gansbacher, 1992, Blood, 80, 2817, 10.1182/blood.V80.11.2817.2817 · doi:10.1182/blood.v80.11.2817.2817
- Merrouche, 1995, Journal of Clinical Oncology, 13, 410, 10.1200/JCO.1995.13.2.410 · DOI
- Sanda, 1995, JNCI Journal of the National Cancer Institute, 87, 280, 10.1093/jnci/87.4.280 · DOI · Paper page
- 1995, Scientific American, 1, 90
- Lehmann, 1995, European journal of immunology, 25, 340, 10.1002/eji.1830250206 · DOI · Paper page
- Grimm, 1988, Cancer immunology, immunotherapy : CII, 27, 53, 10.1007/BF00205758 · doi:10.1007/bf00205758
- Herrmann, 1996, Journal of molecular medicine (Berlin, Germany), 74, 213, 10.1007/BF00204751 · doi:10.1007/bf00204751
- Culver, 1992, Science, 256, 1550, 10.1126/science.1317968 · DOI · Paper page
- Freeman, 1993, Cancer Research, 53, 5274
- Bi, 1993, Human gene therapy, 4, 725, 10.1089/hum.1993.4.6-725 · DOI · Paper page
- Vile, 1994, Cancer Research, 54, 6228
- Hirschowitz, 1995, Human gene therapy, 6, 1055, 10.1089/hum.1995.6.8-1055 · doi:10.1089/hum.1995.6.8-1055
- Khil, 1996, Clinical Cancer Research, 2, 53
- 1995, Cancer gene therapy, 2, 67
- 1995, Human gene therapy, 6, 535, 10.1089/hum.1995.6.4-535 · doi:10.1089/hum.1995.6.4-535
- Mickisch, 1992, Blood, 79, 1087, 10.1182/blood.V79.4.1087.bloodjournal7941087 · DOI
- Sorrentino, 1992, Science, 257, 99, 10.1126/science.1352414 · DOI · Paper page
- Moritz, 1995, Cancer Research, 55, 2608
- May, 1995, Blood, 86, 2439, 10.1182/blood.V86.6.2439.bloodjournal8662439 · DOI
- Spencer, 1996, Blood, 87, 2579, 10.1182/blood.V87.6.2579.bloodjournal8762579 · DOI
- Weinberg, 1991, Science, 254, 1138, 10.1126/science.1659741 · DOI · Paper page
- Bishop, 1991, Cell, 64, 235, 10.1016/0092-8674(91)90636-D · DOI · Paper page
- Marshall, 1991, Trends in genetics : TIG, 7, 91, 10.1016/0168-9525(91)90278-X · DOI
- Mukhopadhyay, 1991, Cancer Research, 51, 1744
- Calabretta, 1991, Cancer Research, 51, 4505
- Zhang, 1993, Human gene therapy, 4, 451, 10.1089/hum.1993.4.4-451 · DOI
- Georges, 1993, Cancer Research, 53, 1743
- 1994, Cancer gene therapy, 1, 333
- Kashani-Sabet, 1994, Cancer Research, 54, 900
- Scanlon, 1991, PNAS, 88, 10591, 10.1073/pnas.88.23.10591 · DOI · Paper page
- Feng, 1995, Cancer Research, 55, 2024
- 1991, 30, 8283, 10.1021/bi00098a001 · DOI
- Richardson, 1995, Trends in biotechnology, 13, 306, 10.1016/S0167-7799(00)88970-2 · DOI
- Knudson, 1990, Cancer Research, 50, 6765
- Liebermann, 1995, Oncogene, 11, 199
- Takahashi, 1992, Cancer Research, 52, 2340
- Goyette, 1992, Molecular and Cellular Biology, 12, 1387, 10.1128/MCB.12.3.1387 · DOI · Paper page
- Cai, 1993, Human gene therapy, 4, 617, 10.1089/hum.1993.4.5-617 · DOI
- Fujiwara, 1994, JNCI Journal of the National Cancer Institute, 86, 1458, 10.1093/jnci/86.19.1458 · DOI · Paper page
- Wang, 1995, Cancer gene therapy, 2, 9
- Liu, 1994, Cancer Research, 54, 3662
- Clayman, 1995, Cancer Research, 55, 1
- 1995, 36, 423
- 1995, 36, 423
- Werthman, 1996, The Journal of urology, 155, 753, 10.1016/S0022-5347(01)66515-7 · DOI
- Badie, 1995, Neurological research, 17, 209, 10.1080/01616412.1995.11740314 · DOI
- Drazan, 1994, Surgery, 116, 197
- Harris, 1996, Cancer gene therapy, 3, 121
- Jin, 1995, Cancer Research, 55, 3250
- Xu, 1996, Cancer Research, 56, 2245
- Rusch, 1995, Cancer Research, 55, 5038
- Lowe, 1993, Cell, 74, 957, 10.1016/0092-8674(93)90719-7 · DOI · Paper page
- Fujiwara, 1994, Cancer Research, 54, 2287
- 1993, Human gene therapy, 4, 451, 10.1089/hum.1993.4.4-451 · DOI
- Fujiwara, 1993, Cancer Research, 53, 4129
- 1995, Biotechnology (Reading, Mass.), 13, 222
- 1995, TUMOR TARGETING, 1, 295
- 1988, 167, 400, 10.1016/0042-6822(88)90101-8 · doi:10.1016/0042-6822(88)90101-8 · Paper page
- 1994, Blood, 84, 359a
- 1995, Cancer gene therapy, 2, 323
- 1995, Gut, 37, A133
- Li, 1993, Human gene therapy, 4, 403, 10.1089/hum.1993.4.4-403 · DOI · Paper page
- 1995, 210, 226, 10.1006/viro.1995.1337 · DOI
- Kremer, 1995, British Medical Bulletin, 51, 31, 10.1093/oxfordjournals.bmb.a072951 · DOI
- Engelhardt, 1993, Human gene therapy, 4, 759, 10.1089/hum.1993.4.6-759 · DOI · Paper page
- 1995, Cancer gene therapy, 2, 225
- Engelhardt, 1994, PNAS, 91, 6196, 10.1073/pnas.91.13.6196 · DOI · Paper page
- Yang, 1994, PNAS, 91, 4407, 10.1073/pnas.91.10.4407 · DOI · Paper page
- Engelhardt, 1994, Human gene therapy, 5, 1217, 10.1089/hum.1994.5.10-1217 · DOI · Paper page
- 1996, 217, 11, 10.1006/viro.1996.0088 · DOI · Paper page
- Yang, 1995, Nature medicine, 1, 890, 10.1038/nm0995-890 · DOI · Paper page
- Dai, 1995, PNAS, 92, 1401, 10.1073/pnas.92.5.1401 · DOI · Paper page
- Fang, 1995, Human gene therapy, 6, 1039, 10.1089/hum.1995.6.8-1039 · DOI
- Roth, 1996, Human gene therapy, 7, 861, 10.1089/hum.1996.7.7-861 · doi:10.1089/hum.1996.7.7-861
- Flotte, 1993, PNAS, 90, 10613, 10.1073/pnas.90.22.10613 · DOI · Paper page
- Halbert, 1995, Journal of Virology, 69, 1473, 10.1128/JVI.69.3.1473-1479.1995 · DOI
- Latchman, 1994, Molecular biotechnology, 2, 179, 10.1007/BF02824809 · DOI
- Peplinski, 1995, Annals of Surgical Oncology, 2, 151, 10.1007/BF02303631 · doi:10.1007/bf02303631
- Hodge, 1994, Cancer Research, 54, 5552
- Wilkinson, 1995, British Medical Bulletin, 51, 205, 10.1093/oxfordjournals.bmb.a072947 · doi:10.1093/oxfordjournals.bmb.a072947
- Forstov, 1995, Human gene therapy, 6, 297, 10.1089/hum.1995.6.3-297 · doi:10.1089/hum.1995.6.3-297
- Nabel, 1992, Human gene therapy, 3, 649, 10.1089/hum.1992.3.6-649 · doi:10.1089/hum.1992.3.6-649
- Das, 1985, Biochemical medicine, 33, 124, 10.1016/0006-2944(85)90135-8 · doi:10.1016/0006-2944(85)90135-8
- Wu, 1987, Journal of Biological Chemistry, 262, 4429, 10.1016/S0021-9258(18)61209-8 · DOI · Paper page
- Wagner, 1990, PNAS, 87, 3410, 10.1073/pnas.87.9.3410 · DOI · Paper page
- Cristiano, 1993, PNAS, 90, 11548, 10.1073/pnas.90.24.11548 · DOI · Paper page
- Bunnell, 1992, Somatic cell and molecular genetics, 18, 559, 10.1007/BF01232652 · DOI
- Cotten, 1992, PNAS, 89, 6094, 10.1073/pnas.89.13.6094 · DOI · Paper page
- Gao, 1993, Human gene therapy, 4, 17, 10.1089/hum.1993.4.1-17 · doi:10.1089/hum.1993.4.1-17
- Davis, 1993, Human gene therapy, 4, 151, 10.1089/hum.1993.4.2-151 · DOI · Paper page
- Acsadi, 1991, The New biologist, 3, 71
- Cheng, 1993, PNAS, 90, 4455, 10.1073/pnas.90.10.4455 · DOI · Paper page
- Nicolet, 1995, Cancer gene therapy, 2, 161
- Miller, 1990, Molecular and Cellular Biology, 10, 4239, 10.1128/MCB.10.8.4239 · DOI · Paper page
- 1993, PNAS, 90, 11548, 10.1073/pnas.90.24.11548 · DOI · Paper page
- Curiel, 1992, Human gene therapy, 3, 147, 10.1089/hum.1992.3.2-147 · DOI · Paper page
- Kasahara, 1994, Science, 266, 1373, 10.1126/science.7973726 · doi:10.1126/science.7973726
- Gottschalk, 1994, Gene therapy, 1, 185
- Ding, 1995, Journal of Biological Chemistry, 270, 3667, 10.1074/jbc.270.8.3667 · doi:10.1074/jbc.270.8.3667
- Cristiano, 1996, Cancer gene therapy, 3, 4
- Muller, 1995, Journal of Virology, 69, 948, 10.1128/JVI.69.2.948-954.1995 · doi:10.1128/jvi.69.2.948-954.1995
- Ghazal, 1987, PNAS, 84, 3658, 10.1073/pnas.84.11.3658 · DOI
- Ponder, 1991, Human gene therapy, 2, 41, 10.1089/hum.1991.2.1-41 · doi:10.1089/hum.1991.2.1-41
- DiMaio, 1994, Surgery, 116, 205
- Smith, 1994, Human gene therapy, 5, 29, 10.1089/hum.1994.5.1-29 · doi:10.1089/hum.1994.5.1-29
- Vile, 1993, Cancer Research, 53, 962
- Gazit, 1995, Cancer Research, 55, 1660
- Wills, 1994, Human gene therapy, 5, 1079, 10.1089/hum.1994.5.9-1079 · DOI · Paper page
- Smythe, 1994, The Annals of Thoracic Surgery, 57, 1395, 10.1016/0003-4975(94)90090-6 · DOI
- Zatloukal, 1995, The Journal of Immunology, 154, 3406, 10.4049/jimmunol.154.7.3406 · DOI
- Bernad, 1994, British journal of haematology, 87, 6, 10.1111/j.1365-2141.1994.tb04863.x · doi:10.1111/j.1365-2141.1994.tb04863.x
- Cole, 1995, Cancer Research, 55, 748
- 1995, Journal of molecular medicine (Berlin, Germany), 73, B13
- Rosenfeld, 1994, Human gene therapy, 5, 331, 10.1089/hum.1994.5.3-331 · DOI
- Weichselbaum, 1994, Cancer Research, 54, 4266
- Son, 1994, PNAS, 91, 12669, 10.1073/pnas.91.26.12669 · DOI
- Chen, 1995, PNAS, 92, 2577, 10.1073/pnas.92.7.2577 · DOI · Paper page
- Crystal, 1994, Nature genetics, 8, 42, 10.1038/ng0994-42 · DOI · Paper page
- Ginsberg, 1990, PNAS, 87, 6191, 10.1073/pnas.87.16.6191 · DOI
- Ginsberg, 1991, PNAS, 88, 1651, 10.1073/pnas.88.5.1651 · DOI · Paper page
- Ginsberg, 1989, PNAS, 86, 3823, 10.1073/pnas.86.10.3823 · DOI · Paper page
- Zhang, 1995, Human gene therapy, 6, 155, 10.1089/hum.1995.6.2-155 · DOI
- Casson, 1991, Cancer Research, 51, 4495
- Bennett, 1993, Cancer Research, 53, 4817
- Stribling, 1992, PNAS, 89, 11277, 10.1073/pnas.89.23.11277 · DOI · Paper page
- Nabel, 1994, Human gene therapy, 5, 1089, 10.1089/hum.1994.5.9-1089 · DOI
- Sobol, 1995, Gene therapy, 2, 164
- Habib, 1996, Cancer detection and prevention, 20, 103
- Roth, 1996, Nature medicine, 2, 985, 10.1038/nm0996-985 · DOI · Paper page
Cited by
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Hortobagyi, G. N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391407 · Cited by 781
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203251 · Cited by 764
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
Apoptosis, cancer and cancer therapy
Bold, R. J., Termuhlen, P. M., & McConkey, D. J. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)00015-7 · Cited by 283
Metadata
- Authors
- Roth, J. A., & Cristiano, R. J.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 89
- Issue
- 1
- Pages
- 21-39
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2121421904
- Cited by
- 635
- References
- 2
- FWCI
- 49.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene Therapy for Cancer: What Have We Done and Where Are We Going? https://app.cochat.ai/papers/10.1093/jnci/89.1.21
- The paper
- Roth, J. A., & Cristiano, R. J. (1997). Gene Therapy for Cancer: What Have We Done and Where Are We Going? JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/89.1.21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.